Advanced Sterilization Products Services Inc.

Advanced Sterilization Products Services Inc., doing business as A S P, is a for-profit manufacturer and service provider of medical device sterilization equipment and related maintenance services, competing as a prime contractor in the unrestricted federal marketplace with no set-aside activity. Headquartered in Irvine, California, and operating as a child entity of Advanced Sterilization Products Italia S.R.L., ASP specializes in low-temperature hydrogen peroxide gas plasma sterilization systems—primarily the STERRAD line of sterilizers and AEROFLEX endoscope reprocessors—along with preventative maintenance, repair, and software support services delivered to federal healthcare agencies.

ASP's federal footprint centers on the Department of Veterans Affairs across multiple Veterans Integrated Service Networks, which account for the preponderance of its customer concentration. By award count, the top five funding agencies comprise 44% of recent awards: Defense Health Agency (40 awards, $6.4 million), VA VISN 6 (32 awards, $4.3 million), VA VISN 15 (29 awards, $4.5 million), VA VISN 4 (25 awards, $1.8 million), and VA VISN 22 (21 awards, $6.3 million). By potential value, the concentration shifts: VA VISN 12 anchors 61% of the top-five customer dollars ($20.9 million across six awards, predominantly single large maintenance contracts), while Defense Health Agency and VA VISN 22 remain in the top tier. This divergence reflects ASP's heavy reliance on multi-year sole-source maintenance agreements at specific VA facilities, particularly VISN 12's Milwaukee-area medical centers, combined with frequent smaller equipment and repair purchases across distributed VISNs.

Representative prime work includes a $988.7 million maintenance services contract with VA VISN 12 running through October 31, 2027 (awarded November 1, 2022); a $642.6 million Defense Health Agency sterilizer and washer maintenance order for Portsmouth, Virginia through September 30, 2028 (October 1, 2023); a $570.5 million VA VISN 21 preventive maintenance and repair package for Southern Nevada Healthcare System through December 10, 2026 (December 11, 2023); a $546.6 million VA VISN 1 STERRAD preventive maintenance award for Connecticut Healthcare System through June 25, 2029 (June 26, 2024); and a $1.1 million VA VISN 22 STERRAD sterilizer maintenance contract at Long Beach through August 31, 2027 (September 1, 2022). Equipment procurements range from $45 thousand to $369 thousand for STERRAD NX, STERRAD 100NX, and EVOTECH systems. ASP also receives blanket purchase agreement calls from VA VISN 15 ($200.5 thousand to $259.4 thousand ceilings) that support year-to-year consumables and service orders across the Midwest network.

Vehicle position reflects ASP's reliance on indefinite-delivery contracts and blanket purchase agreements with the VA and Defense Health Agency rather than government-wide vehicles. The top contract vehicles include VA VISN IDCs and BPAs—notably five separate VISN 15 BPA vehicles with ceilings ranging from $86 thousand to $259 thousand—plus a GSA Medical Equipment and Supplies schedule (FSS-65-II-A) placing eight task orders worth $520 thousand. Few orders flow through centralized GWACs or agency-wide IDIQs; ASP's customer access is primarily through direct VISN-level sole-source awards justified by original equipment manufacturer status and proprietary maintenance authorization requirements.

Activity has remained relatively flat year over year, with 54 awards in 2022, 60 in 2023, 53 in 2024, 37 in 2025, and 16 in the first half of 2026, suggesting stable but not accelerating federal engagement. The recompete cliff shows 56 awards (combined potential value $9.9 million) completing within the next twenty-four months, representing modest near-term recompete exposure concentrated across VISN maintenance contracts due for renewal in FY2027 and FY2028. ASP holds 330 of 333 recent awards as prime contractor (99%), with only three sub-awards from Cardinal Health 200 LLC in the source data, indicating ASP operates as a self-performing vendor rather than a strategic subcontractor to larger primes.

Service Contract Inventory data shows sparse SCI-reportable invoicing due to ASP's goods-dominant business model: $702 thousand in FY2023 across 0.3 FTEs, with $0 reported in FY2022 and FY2024. The median government-paid hourly rate on SCI-reportable work sat around $1,022 per hour, with senior labor pricing reaching the 90th percentile at approximately $1,312 per hour. Across SCI-reportable prime contracts, ASP self-performed 100% of contractor hours, signaling no reliance on named subcontractors for service delivery and alignment with its role as a proprietary OEM service provider. The low SCI footprint reflects ASP's emphasis on product sales (sterilization equipment) and firm fixed-price maintenance packages, both of which fall outside the SCI reporting threshold or are classified as goods rather than services.

ASP's competitive posture is defined by sole-source and limited-competition awards justified under Federal Acquisition Regulation authority citing proprietary STERRAD maintenance procedures, OEM certification requirements, and brand-name product specifications. The vendor competes full-and-open on equipment procurements but rarely faces competition on maintenance renewals, positioning it as an entrenched supplier within VA sterile processing operations. Customer concentration around VA VISN networks and Defense Health Agency indicates narrow federal healthcare exposure with minimal diversification into civilian agencies, research, or DoD combat support functions. The parent-child structure with Advanced Sterilization Products Italia S.R.L. has not generated visible corporate restructuring or rebranding activity in recent federal awards, suggesting stable operational continuity under the existing A S P brand and Irvine headquarters.